A
Antoni Martínez-Rubio
Researcher at Autonomous University of Barcelona
Publications - 25
Citations - 327
Antoni Martínez-Rubio is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 7, co-authored 25 publications receiving 252 citations.
Papers
More filters
Journal ArticleDOI
Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
José Ramón González-Juanatey,José Alvarez-Sabín,José María Lobos,Antoni Martínez-Rubio,Joan Carles Reverter,Itziar Oyagüez,Nuria González-Rojas,Virginia Becerra +7 more
TL;DR: Dabigatran resulta una estrategia eficiente para the prevencion of ictus en pacientes con fibrilacion auricular no valvular en comparacion con warfarina y con el patron de prescripcion habitual.
Journal ArticleDOI
Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.
José Ramón González-Juanatey,José Alvarez-Sabín,José María Lobos,Antoni Martínez-Rubio,Joan Carles Reverter,Itziar Oyagüez,Nuria González-Rojas,Virginia Becerra +7 more
TL;DR: Dabigatran is an efficient strategy for the prevention of stroke in patients with non-valvular atrial fibrillation compared to warfarin and to the real-world prescribing pattern; incremental cost-effectiveness ratios were below the 30 000 euros/quality-adjusted life year threshold in both scenarios.
Journal ArticleDOI
World Heart Federation Roadmap for Heart Failure.
João Pedro Ferreira,Sarah Kraus,Sharon Mitchell,Pablo Perel,Daniel J. Piñeiro,Ovidiu Chioncel,Roberto Colque,Rudolf A. de Boer,Juan Esteban Gomez-Mesa,Hugo Grancelli,Carolyn S.P. Lam,Antoni Martínez-Rubio,John J.V. McMurray,Alexandre Mebazaa,Gurusher Panjrath,Ileana L. Piña,Mahmoud U Sani,David Sim,Mary Norine Walsh,Clyde W. Yancy,Faiez Zannad,Karen Sliwa +21 more
TL;DR: This consensus document offers a pathway of care that is the foundation from which to assess barriers that are context-specific and evidence-based solutions to specific roadblocks are offered in tables within the document.
Journal ArticleDOI
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update
Ben Freedman,Gerhard Hindricks,Amitava Banerjee,Adrian Baranchuk,Chi Keong Ching,Xin Du,Donna Fitzsimons,Jeff S. Healey,Takanori Ikeda,Trudie Lobban,Amam Mbakwem,Calambur Narasimhan,Lis Neubeck,Peter A. Noseworthy,Daniel M Philbin,Fausto J. Pinto,Joselyn Rwebembera,Renate B. Schnabel,Jesper Hastrup Svendsen,Luis Aguinaga,Elena Arbelo,Michael Böhm,Hasan Ali Farhan,FD Richard Hobbs,Antoni Martínez-Rubio,Claudio Militello,Nitish Naik,Jean Jacques Noubiap,Pablo Perel,Daniel J. Piñeiro,Antonio Luiz Pinho Ribeiro,Janina Stępińska +31 more
TL;DR: The World Heart Federation (WHF) initiated a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs as mentioned in this paper, where the goal was to provide guidance on priority interventions that are feasible in multiple countries, and to identify roadblocks and potential strategies to overcome them.
Journal ArticleDOI
Evaluación de riesgo tromboembólico y hemorrágico de los pacientes con fibrilación auricular
Josep Guindo Soldevila,María Dolores Martínez Ruiz,Ignasi Duran Robert,Pilar Tornos,Antoni Martínez-Rubio +4 more
TL;DR: Esta demostrado que el tratamiento antitrombotico con anticoagulantes orales se asocia a un drastico descenso del riesgo de accidentes tromboembolicos arteriales, de las que es especialmente devastadora the hemorragia intracraneal.